Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01269372 · ClinicalTrials.gov registry record · NA

Evaluation of Capsule Endoscopy With PillCam® Colon 2 in Visualization of the Colon

A NA study of Colorectal Lesions, sponsored by Medtronic - MITG.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT01269372 is a NA study of Colorectal Lesions that has completed, run by Medtronic - MITG. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01269372, a NA study of Colorectal Lesions, has completed, sponsored by Medtronic - MITG.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This pilot, multi center study will establish the effectiveness of Given PillCam® Platform with the PillCam® Colon 2 Capsule as demonstrated by the identification of subjects with polyps, compared to standard colonoscopy. This study will also use to evaluate the administrative feasibility and data management of study design.

Conditions Studied

Interventions

  • DEVICE PillCam Colon 2
  • DEVICE Colonoscopy

Study Locations (1)

Virginia

  • Gastroenterology Associates of Tidewater - Chesapeake

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2010-12
Est. Completion 2011-07
Phase NA

Sponsor

Medtronic - MITG

119 total trials

What the Registry Record Tells You About NCT01269372

The ClinicalTrials.gov registry entry for NCT01269372 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colorectal Lesions appearing as the primary indexed condition, and to 2 interventions - of which PillCam Colon 2 is the first listed.

NCT01269372 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT01269372 about?

NCT01269372 is a clinical study titled "Evaluation of Capsule Endoscopy With PillCam® Colon 2 in Visualization of the Colon". This pilot, multi center study will establish the effectiveness of Given PillCam® Platform with the PillCam® Colon 2 Capsule as demonstrated by the identification of subjects with polyps, compared to standard colonoscopy. This study will also use to evaluate the administrative feasibility and data ...

What is the current status of trial NCT01269372?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2010-12. Estimated completion is 2011-07.

What conditions does trial NCT01269372 study?

This clinical trial studies the following conditions: Colorectal Lesions.

What interventions are being tested in trial NCT01269372?

The interventions under investigation include: PillCam Colon 2 (DEVICE), Colonoscopy (DEVICE).

Who is sponsoring clinical trial NCT01269372?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01269372 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.